Search Results - "KAWABE, KAZUKI"
-
1
Silodosin, a new α1A‐adrenoceptor‐selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo‐controlled, double‐blind study in Japanese men
Published in BJU international (01-11-2006)“…This section contains papers from Japan, Austria, the UK, and joint papers from France, Denmark, Switzerland, Australia and the USA. A wide variety of lower…”
Get full text
Journal Article -
2
Development of Highly Selective Process for Mono-Ethylene Glycol Production from Ethylene Oxide via Ethylene Carbonate Using Phosphonium Salt Catalyst
Published in Catalysis Surveys from Asia (01-09-2010)“…A new process for the production of mono-ethylene glycol (MEG; HOCH 2 CH 2 OH) was developed by Mitsubishi Chemical Corporation (MCC) to meet its growing…”
Get full text
Journal Article -
3
New clinical evidence of silodosin, an α1A selective adrenoceptor antagonist, in the treatment for lower urinary tract symptoms
Published in International journal of urology (01-04-2012)“…Lower urinary tract symptoms associated with benign prostatic hyperplasia are highly prevalent in older men. Pharmacological treatment is the first‐line…”
Get full text
Journal Article -
4
New clinical evidence of silodosin, an α(1A) selective adrenoceptor antagonist, in the treatment for lower urinary tract symptoms
Published in International journal of urology (01-04-2012)“…Lower urinary tract symptoms associated with benign prostatic hyperplasia are highly prevalent in older men. Pharmacological treatment is the first-line…”
Get full text
Journal Article -
5
Prediction of α1-Adrenoceptor Occupancy in the Human Prostate from Plasma Concentrations of Silodosin, Tamsulosin and Terazosin to Treat Urinary Obstruction in Benign Prostatic Hyperplasia
Published in Biological & Pharmaceutical Bulletin (01-07-2007)“…α1-Adrenoceptor antagonists are clinically useful for the improvement of urinary obstruction due to benign prostatic hyperplasia (BPH), and their therapeutic…”
Get full text
Journal Article -
6
Habitual intake of lactic acid bacteria and risk reduction of bladder cancer
Published in Urologia internationalis (01-01-2002)“…A kind of lactic acid bacteria, Lactobacillus casei strain Shirota, shows antitumor activity in experimental animals. One clinical trial using L. casei showed…”
Get more information
Journal Article -
7
How frequent are invasive therapies required in patients receiving tamsulosin for benign prostatic hyperplasia? A retrospective long-term study
Published in International journal of urology (01-02-2006)“…Three hundred Japanese patients with benign prostatic hyperplasia (BPH) who started an α1‐adrenoceptor blocker, tamsulosin, between 1993 and 1996 were followed…”
Get full text
Journal Article -
8
Latest Frontiers in Pharmacotherapy for Benign Prostatic Hyperplasia
Published in YAKUGAKU ZASSHI (2006)“…α1-Adrenoceptor antagonists, called α1-blockers, are the first-line treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia…”
Get full text
Journal Article -
9
Quantification and distribution of α1‐adrenoceptor subtype mRNAs in human prostate: comparison of benign hypertrophied tissue and non‐hypertrophied tissue
Published in British journal of pharmacology (01-11-1996)“…1 There are at least three α 1‐adrenoceptor subtypes, α1a, α1b and α1d, in human tissues. Using an RNase protection assay, we have now determined the amount of…”
Get full text
Journal Article -
10
Prediction of alpha1-adrenoceptor occupancy in the human prostate from plasma concentrations of silodosin, tamsulosin and terazosin to treat urinary obstruction in benign prostatic hyperplasia
Published in Biological & pharmaceutical bulletin (2007)“…Alpha1-adrenoceptor antagonists are clinically useful for the improvement of urinary obstruction due to benign prostatic hyperplasia (BPH), and their…”
Get full text
Journal Article -
11
Quantification and distribution of α1‐adrenoceptor subtype mRNAs in human proximal urethra
Published in British journal of pharmacology (01-04-1998)“…We performed RNase protection assays and in situ hybridization to investigate the ratio of the three α1‐adrenoceptor subtype mRNAs, α1a, α1b and α1d, in human…”
Get full text
Journal Article -
12
Transvaginal ultrasound of urethral sphincter at the mid urethra in continent and incontinent women
Published in The Journal of urology (01-01-2001)“…Few studies are available on imaging the urethral sphincter. We performed transvaginal ultrasonography to examine the muscle in continent and incontinent…”
Get more information
Journal Article -
13
Increased incidental detection and reduced mortality in renal cancer--recent retrospective analysis at eight institutions
Published in International journal of urology (01-05-1995)“…A retrospective survey of renal cell carcinoma between 1975 and 1993 at eight collaborating institutions was conducted with special reference to the incidental…”
Get more information
Journal Article -
14
Electromyographic study of the striated urethral sphincter in type 3 stress incontinence: evidence of myogenic-dominant damages
Published in Urology (Ridgewood, N.J.) (01-12-2000)“…Objectives. To determine the electromyographic features of the striated urethral sphincter in patients with type 3 stress incontinence (SI) due to intrinsic…”
Get full text
Journal Article -
15
Butyrolactone I induces cyclin B1 and causes G2/M arrest and skipping of mitosis in human prostate cell lines
Published in Cancer letters (26-04-1999)“…Several naturally occurring cyclin-dependent kinase (CDK) inhibitors have been isolated from different lower organisms. In this report, we examined the effect…”
Get full text
Journal Article -
16
A Clinical Study of PMCJ-9 (Bacillus Calmette–Guérin Connaught Strain) Treatment of Superficial Bladder Cancer and Carcinoma In Situ of the Bladder
Published in Japanese journal of clinical oncology (01-08-2003)“…Background: Intravesical Bacillus Calmette–Guérin (BCG) is now a standard treatment for Ta, T1 carcinoma and carcinoma in situ (CIS) of the urinary bladder…”
Get full text
Journal Article -
17
In vivo receptor binding of novel α1-adrenoceptor antagonists for treatment of benign prostatic hyperplasia
Published in Life sciences (1973) (01-03-1998)“…New types of α 1-adrenoceptor antagonists (tamsulosin, KMD-3213 and JTH-601) are currently receiving a great deal of attention, especially in terms of…”
Get full text
Journal Article -
18
Effect of Bcl-2 overexpression in human prostate cancer cells in vitro and in vivo
Published in International journal of urology (01-10-1999)“…Background : Cancer cells often develop mechanisms to resist apoptosis and the extent of such anti‐apoptotic ability has been shown to parallel tumor…”
Get full text
Journal Article -
19
Ejaculation Disorder Is Associated With Increased Efficacy of Silodosin for Benign Prostatic Hyperplasia
Published in Urology (Ridgewood, N.J.) (01-12-2010)“…Objectives To provide clinical evidence that ejaculation disorder caused by selective alpha1A -blockers may be associated with larger symptomatic improvements…”
Get full text
Journal Article -
20
A new portable measuring cup for voided volume
Published in International journal of urology (01-07-2001)“…When recording daily urine volumes for the frequency–volume chart, a patient must measure voided urine volume throughout the whole day. Unless the patient…”
Get full text
Journal Article